Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel Free KRMD Stock Alerts

KORU Medical Systems (KRMD) Competitors

KORU Medical Systems logo
$4.01 -0.05 (-1.23%)
As of 11:39 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

KRMD vs. BBNX, CBLL, SSII, SGP, and TCMD

Should you buy KORU Medical Systems stock or one of its competitors? MarketBeat compares KORU Medical Systems with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with KORU Medical Systems include Beta Bionics (BBNX), CeriBell (CBLL), SS Innovations International (SSII), Spyglass Pharma (SGP), and Tactile Systems Technology (TCMD). These companies are all part of the "medical equipment" industry.

How does KORU Medical Systems compare to Beta Bionics?

KORU Medical Systems (NASDAQ:KRMD) and Beta Bionics (NASDAQ:BBNX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, valuation, risk, earnings, media sentiment, institutional ownership and dividends.

In the previous week, KORU Medical Systems had 1 more articles in the media than Beta Bionics. MarketBeat recorded 1 mentions for KORU Medical Systems and 0 mentions for Beta Bionics. KORU Medical Systems' average media sentiment score of 0.00 equaled Beta Bionics'average media sentiment score.

Company Overall Sentiment
KORU Medical Systems Neutral
Beta Bionics Neutral

KORU Medical Systems has higher earnings, but lower revenue than Beta Bionics. KORU Medical Systems is trading at a lower price-to-earnings ratio than Beta Bionics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KORU Medical Systems$41.13M4.48-$2.64M-$0.05N/A
Beta Bionics$100.25M7.80-$73.20M-$1.51N/A

KORU Medical Systems has a beta of 0.41, indicating that its stock price is 59% less volatile than the broader market. Comparatively, Beta Bionics has a beta of 3.04, indicating that its stock price is 204% more volatile than the broader market.

58.6% of KORU Medical Systems shares are held by institutional investors. 18.5% of KORU Medical Systems shares are held by company insiders. Comparatively, 5.3% of Beta Bionics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

KORU Medical Systems has a net margin of -5.27% compared to Beta Bionics' net margin of -60.27%. KORU Medical Systems' return on equity of -13.61% beat Beta Bionics' return on equity.

Company Net Margins Return on Equity Return on Assets
KORU Medical Systems-5.27% -13.61% -8.33%
Beta Bionics -60.27%-23.00%-20.55%

KORU Medical Systems currently has a consensus price target of $7.25, suggesting a potential upside of 80.80%. Beta Bionics has a consensus price target of $20.30, suggesting a potential upside of 15.74%. Given KORU Medical Systems' higher probable upside, research analysts clearly believe KORU Medical Systems is more favorable than Beta Bionics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
Beta Bionics
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.64

Summary

KORU Medical Systems beats Beta Bionics on 9 of the 16 factors compared between the two stocks.

How does KORU Medical Systems compare to CeriBell?

KORU Medical Systems (NASDAQ:KRMD) and CeriBell (NASDAQ:CBLL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, media sentiment, institutional ownership, risk, valuation, profitability and dividends.

KORU Medical Systems has higher earnings, but lower revenue than CeriBell. KORU Medical Systems is trading at a lower price-to-earnings ratio than CeriBell, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KORU Medical Systems$41.13M4.48-$2.64M-$0.05N/A
CeriBell$95.07M7.33-$53.41M-$1.63N/A

58.6% of KORU Medical Systems shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by insiders. Comparatively, 20.1% of CeriBell shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

KORU Medical Systems has a net margin of -5.27% compared to CeriBell's net margin of -63.51%. KORU Medical Systems' return on equity of -13.61% beat CeriBell's return on equity.

Company Net Margins Return on Equity Return on Assets
KORU Medical Systems-5.27% -13.61% -8.33%
CeriBell -63.51%-38.19%-30.92%

In the previous week, KORU Medical Systems and KORU Medical Systems both had 1 articles in the media. KORU Medical Systems' average media sentiment score of 0.00 equaled CeriBell'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
KORU Medical Systems
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
CeriBell
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

KORU Medical Systems has a beta of 0.41, meaning that its share price is 59% less volatile than the broader market. Comparatively, CeriBell has a beta of 0.77, meaning that its share price is 23% less volatile than the broader market.

KORU Medical Systems presently has a consensus price target of $7.25, indicating a potential upside of 80.80%. CeriBell has a consensus price target of $22.20, indicating a potential upside of 20.88%. Given KORU Medical Systems' higher possible upside, equities analysts plainly believe KORU Medical Systems is more favorable than CeriBell.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
CeriBell
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.83

Summary

KORU Medical Systems and CeriBell tied by winning 7 of the 14 factors compared between the two stocks.

How does KORU Medical Systems compare to SS Innovations International?

SS Innovations International (NASDAQ:SSII) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation.

In the previous week, SS Innovations International had 12 more articles in the media than KORU Medical Systems. MarketBeat recorded 13 mentions for SS Innovations International and 1 mentions for KORU Medical Systems. SS Innovations International's average media sentiment score of 0.42 beat KORU Medical Systems' score of 0.00 indicating that SS Innovations International is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SS Innovations International
3 Very Positive mention(s)
3 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
KORU Medical Systems
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

58.6% of KORU Medical Systems shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

KORU Medical Systems has lower revenue, but higher earnings than SS Innovations International. KORU Medical Systems is trading at a lower price-to-earnings ratio than SS Innovations International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SS Innovations International$42.49M17.34-$12.13M-$0.05N/A
KORU Medical Systems$41.13M4.48-$2.64M-$0.05N/A

SS Innovations International has a beta of -1.96, indicating that its stock price is 296% less volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.41, indicating that its stock price is 59% less volatile than the broader market.

KORU Medical Systems has a net margin of -5.27% compared to SS Innovations International's net margin of -20.69%. KORU Medical Systems' return on equity of -13.61% beat SS Innovations International's return on equity.

Company Net Margins Return on Equity Return on Assets
SS Innovations International-20.69% -23.00% -13.18%
KORU Medical Systems -5.27%-13.61%-8.33%

SS Innovations International currently has a consensus target price of $7.00, indicating a potential upside of 90.17%. KORU Medical Systems has a consensus target price of $7.25, indicating a potential upside of 80.80%. Given SS Innovations International's higher probable upside, analysts plainly believe SS Innovations International is more favorable than KORU Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SS Innovations International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60

Summary

KORU Medical Systems beats SS Innovations International on 9 of the 15 factors compared between the two stocks.

How does KORU Medical Systems compare to Spyglass Pharma?

KORU Medical Systems (NASDAQ:KRMD) and Spyglass Pharma (NASDAQ:SGP) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, media sentiment, dividends and earnings.

58.6% of KORU Medical Systems shares are held by institutional investors. 18.5% of KORU Medical Systems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

KORU Medical Systems currently has a consensus target price of $7.25, suggesting a potential upside of 80.80%. Spyglass Pharma has a consensus target price of $45.00, suggesting a potential upside of 116.55%. Given Spyglass Pharma's stronger consensus rating and higher possible upside, analysts plainly believe Spyglass Pharma is more favorable than KORU Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
Spyglass Pharma
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

In the previous week, Spyglass Pharma had 5 more articles in the media than KORU Medical Systems. MarketBeat recorded 6 mentions for Spyglass Pharma and 1 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 0.00 beat Spyglass Pharma's score of -0.12 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
KORU Medical Systems
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Spyglass Pharma
0 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Spyglass Pharma has a net margin of 0.00% compared to KORU Medical Systems' net margin of -5.27%. Spyglass Pharma's return on equity of 0.00% beat KORU Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
KORU Medical Systems-5.27% -13.61% -8.33%
Spyglass Pharma N/A N/A N/A

Spyglass Pharma has lower revenue, but higher earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Spyglass Pharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KORU Medical Systems$41.13M4.48-$2.64M-$0.05N/A
Spyglass PharmaN/AN/AN/A-$6.41N/A

Summary

Spyglass Pharma beats KORU Medical Systems on 8 of the 13 factors compared between the two stocks.

How does KORU Medical Systems compare to Tactile Systems Technology?

KORU Medical Systems (NASDAQ:KRMD) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, media sentiment, dividends and earnings.

KORU Medical Systems currently has a consensus target price of $7.25, suggesting a potential upside of 80.80%. Tactile Systems Technology has a consensus target price of $38.60, suggesting a potential upside of 34.78%. Given KORU Medical Systems' higher possible upside, equities analysts plainly believe KORU Medical Systems is more favorable than Tactile Systems Technology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
Tactile Systems Technology
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.86

In the previous week, Tactile Systems Technology had 1 more articles in the media than KORU Medical Systems. MarketBeat recorded 2 mentions for Tactile Systems Technology and 1 mentions for KORU Medical Systems. Tactile Systems Technology's average media sentiment score of 0.42 beat KORU Medical Systems' score of 0.00 indicating that Tactile Systems Technology is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
KORU Medical Systems
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Tactile Systems Technology
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Tactile Systems Technology has a net margin of 5.91% compared to KORU Medical Systems' net margin of -5.27%. Tactile Systems Technology's return on equity of 9.70% beat KORU Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
KORU Medical Systems-5.27% -13.61% -8.33%
Tactile Systems Technology 5.91%9.70%7.53%

KORU Medical Systems has a beta of 0.41, meaning that its stock price is 59% less volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.79, meaning that its stock price is 21% less volatile than the broader market.

58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are held by institutional investors. 18.5% of KORU Medical Systems shares are held by insiders. Comparatively, 2.1% of Tactile Systems Technology shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Tactile Systems Technology has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KORU Medical Systems$41.13M4.48-$2.64M-$0.05N/A
Tactile Systems Technology$329.52M1.96$19.09M$0.8832.55

Summary

Tactile Systems Technology beats KORU Medical Systems on 13 of the 16 factors compared between the two stocks.

Get KORU Medical Systems News Delivered to You Automatically

Sign up to receive the latest news and ratings for KRMD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KRMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KRMD vs. The Competition

Export
MetricKORU Medical SystemsMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$184.18M$1.79B$6.80B$12.40B
Dividend YieldN/AN/A2.67%9.39%
P/E Ratio-80.2075.5127.0824.12
Price / Sales4.4825.81516.4792.58
Price / CashN/A27.2926.6847.25
Price / Book10.845.3910.636.23
Net Income-$2.64M-$54.76M$3.60B$331.53M
7 Day Performance-3.37%-1.78%-1.08%-1.30%
1 Month Performance2.82%0.00%1.28%-1.40%
1 Year Performance15.90%-2.43%24.71%18.15%

KORU Medical Systems Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KRMD
KORU Medical Systems
3.7065 of 5 stars		$4.01
-1.2%		$7.25
+80.8%		+20.5%$184.18M$41.13MN/A80
BBNX
Beta Bionics
1.5355 of 5 stars		$16.86
-0.5%		$20.10
+19.2%		+31.1%$755.32M$100.25MN/A294
CBLL
CeriBell
1.7405 of 5 stars		$19.13
-2.0%		$22.20
+16.0%		+18.3%$740.65M$95.07MN/AN/A
SSII
SS Innovations International
2.2505 of 5 stars		$3.67
+0.8%		$7.00
+90.7%		-52.7%$728.48M$42.49MN/A4
SGP
Spyglass Pharma
1.7095 of 5 stars		$19.99
+0.5%		$45.00
+125.1%		N/A$668.33MN/AN/A65

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:KRMD) was last updated on 7/21/2026 by MarketBeat.com Staff.
From Our Partners
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Elon’s new "tollbooth"
The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...
Weiss Ratings | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel